International Chemical acquired Genzyme's pharmaceutical intermediates business, excluding the drug delivery technologies.

Genzyme Corp.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

International Chemical Investors Group

Luxembourg / Financial

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced